The history of Viagra and its originator, copyright, presents a complex picture for cautious investors. While the blockbuster drug initially fueled enormous profits , its exclusivity has expired , leading to generic options flooding the arena. This reduction in pricing presents a significant challenge for copyright and any fund considering a large